The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
Chemical Compound Review

AFMU     N-(4-formamido-1-methyl-2,6- dioxo-3H...

Synonyms: AG-H-43745, CHEBI:32643, HMDB11105, CTK8D4667, AR-1G6930, ...
Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.

Disease relevance of Acetamide, N-(4-(formylamino)-1,2,3,6-tetrahydro-1-methyl-2,6-dioxo-5-pyrimidinyl)-


High impact information on Acetamide, N-(4-(formylamino)-1,2,3,6-tetrahydro-1-methyl-2,6-dioxo-5-pyrimidinyl)-


Biological context of Acetamide, N-(4-(formylamino)-1,2,3,6-tetrahydro-1-methyl-2,6-dioxo-5-pyrimidinyl)-


Associations of Acetamide, N-(4-(formylamino)-1,2,3,6-tetrahydro-1-methyl-2,6-dioxo-5-pyrimidinyl)- with other chemical compounds


  1. Debrisoquine hydroxylation phenotype, acetylation phenotype, and ABO blood groups as genetic host factors of lung cancer risk. Roots, I., Drakoulis, N., Ploch, M., Heinemeyer, G., Loddenkemper, R., Minks, T., Nitz, M., Otte, F., Koch, M. Klin. Wochenschr. (1988) [Pubmed]
  2. Arylamine N-acetyltransferase (NAT2) mutations and their allelic linkage in unrelated Caucasian individuals: correlation with phenotypic activity. Cascorbi, I., Drakoulis, N., Brockmöller, J., Maurer, A., Sperling, K., Roots, I. Am. J. Hum. Genet. (1995) [Pubmed]
  3. Effect of interferon alpha-ribavirin bitherapy on cytochrome P450 1A2 and 2D6 and N-acetyltransferase-2 activities in patients with chronic active hepatitis C. Becquemont, L., Chazouilleres, O., Serfaty, L., Poirier, J.M., Broly, F., Jaillon, P., Poupon, R., Funck-Brentano, C. Clin. Pharmacol. Ther. (2002) [Pubmed]
  4. N-acetyltransferase 2 polymorphism in patients infected with human immunodeficiency virus. Kaufmann, G.R., Wenk, M., Taeschner, W., Peterli, B., Gyr, K., Meyer, U.A., Haefeli, W.E. Clin. Pharmacol. Ther. (1996) [Pubmed]
  5. A population and family study of N-acetyltransferase using caffeine urinary metabolites. Bechtel, Y.C., Bonaiti-Pellie, C., Poisson, N., Magnette, J., Bechtel, P.R. Clin. Pharmacol. Ther. (1993) [Pubmed]
  6. Determination of CYP1A2 and NAT2 phenotypes in human populations by analysis of caffeine urinary metabolites. Butler, M.A., Lang, N.P., Young, J.F., Caporaso, N.E., Vineis, P., Hayes, R.B., Teitel, C.H., Massengill, J.P., Lawsen, M.F., Kadlubar, F.F. Pharmacogenetics (1992) [Pubmed]
  7. A simplified and rapid test for acetylator phenotyping by use of the peak height ratio of two urinary caffeine metabolites. el-Yazigi, A., Chaleby, K., Martin, C.R. Clin. Chem. (1989) [Pubmed]
  8. Extractionless method for the simultaneous high-performance liquid chromatographic determination of urinary caffeine metabolites for N-acetyltransferase 2, cytochrome P450 1A2 and xanthine oxidase activity assessment. Nyéki, A., Biollaz, J., Kesselring, U.W., Décosterd, L.A. J. Chromatogr. B Biomed. Sci. Appl. (2001) [Pubmed]
WikiGenes - Universities